An epidemiological study exploring a possible impact of treatment with ACE inhibitors or angiotensin receptor blockers on ACE2 plasma concentrations.

Wild, Philipp S; Dimmeler, Stefanie; Eschenhagen, Thomas

Wild, Philipp S; Dimmeler, Stefanie; Eschenhagen, Thomas.

Wild PS; Clinical Epidemiology and Systems Medicine, Center for Thrombosis and Hemostasis, University Medical Center, Johannes Gutenberg University of Mainz, Germany; Preventive Cardiology, Center for Cardiology, University Medical Center, Johannes Gutenberg University of Mainz, Germany; German Center for Cardiovascular Research (DZHK), Germany.
Dimmeler S; German Center for Cardiovascular Research (DZHK), Germany; Institute of Cardiovascular Regeneration, Johann Wolfgang Goethe-University of Frankfurt, Germany.
Eschenhagen T; German Center for Cardiovascular Research (DZHK), Germany; Institute of Experimental Pharmacology and Toxicology, University Medical Center Hamburg Eppendorf, Germany. Electronic address: t.eschenhagen@uke.de.

J Mol Cell Cardiol ; 141: 108-109, 2020 04.

Article in English | MEDLINE | ID: covidwho-34780

Subject(s)

Angiotensin Receptor Antagonists/pharmacology; Angiotensin-Converting Enzyme Inhibitors/pharmacology; Epidemiologic Studies; Angiotensin-Converting Enzyme 2; COVID-19/blood; COVID-19/enzymology; COVID-19/epidemiology; Humans; Polymorphism, Single Nucleotide/genetics; Risk Factors

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Angiotensin-Converting Enzyme Inhibitors / Epidemiologic Studies / Angiotensin Receptor Antagonists Type of study: Experimental Studies / Observational study / Prognostic study Limits: Humans Language: English Journal: J Mol Cell Cardiol Year: 2020 Document Type: Article Affiliation country: J.yjmcc.2020.03.018

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google